These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7328996)

  • 21. [Initial resistance to streptomycin, isoniazid, rifampicin and ethambutol in bacillus-laden tuberculosis patients at the National Center of Pneumo-physiology at Cotonou (Benin)].
    Anagonou SY; Gninafon M; Josse R; Kinde-Gazard D; Tawo L; Foundohou J
    Bull Soc Pathol Exot; 1993; 86(2):144-7. PubMed ID: 8353477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Severe hypoprothrombinemia in a tubercular patient treated by combined rifampicin, isoniazid, streptomycin and prothionamide].
    Hinaut G; Bosio AM; Estampes B
    Rev Tuberc Pneumol (Paris); 1970 Mar; 34(2):291-5. PubMed ID: 5510315
    [No Abstract]   [Full Text] [Related]  

  • 23. [A long-term observation on previously treated cases of pulmonary tuberculosis retreated with rifampicin for more than six months (author's transl)].
    Tamura M; Takazawa N; Asada T; Ikegaki H; Yamada M; Kushiro S; Tada T
    Kekkaku; 1979 May; 54(5):285-95. PubMed ID: 113607
    [No Abstract]   [Full Text] [Related]  

  • 24. A follow-up study of 134 cases of pulmonary tuberculosis treated with adequate chemotherapy in 1953-1954.
    Cheung OT; Pugsley HE
    Can Med Assoc J; 1968 Jun; 98(25):1182-3. PubMed ID: 5657185
    [No Abstract]   [Full Text] [Related]  

  • 25. [56 recent pulmonary tuberculosis cases treated with combined rifampicin-isoniazid in a controlled experiment].
    Constans P; Morin Y; Saint-Paul M; Bonnaud G; Coury C; Bariéty M
    Rev Tuberc Pneumol (Paris); 1969 Mar; 33(2):145-62. PubMed ID: 4916251
    [No Abstract]   [Full Text] [Related]  

  • 26. [Principles of rational tuberculosis chemotherapy].
    Khomenko AG
    Antibiotiki; 1980 Jul; 25(7):534-9. PubMed ID: 7406466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Rifampicin, isoniazid (and streptomycin). (therapeutic results in primary complex pulmonary tuberculosis)].
    Fréour P; Bernadou M; Chomy P; Bollinelli J; Wanou JJ
    Rev Tuberc Pneumol (Paris); 1970; 34(5):698-706. PubMed ID: 5496791
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative evaluation of rifampicin and isoniazid penetration into the pathological foci of the lungs in tuberculosis patients].
    Kislitsyna NA
    Probl Tuberk; 1985; (4):55-7. PubMed ID: 4001111
    [No Abstract]   [Full Text] [Related]  

  • 30. National anti-tuberculosis drug resistance survey, 2002, in Myanmar.
    Ti T; Lwin T; Mar TT; Maung W; Noe P; Htun A; Kluge HH; Wright A; Aziz MA; Paramasivan CN
    Int J Tuberc Lung Dis; 2006 Oct; 10(10):1111-6. PubMed ID: 17044203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pyridoxine metabolism in pulmonary tuberculosis patients under rifampicin therapy in combination with isoniazid].
    Baĭramaliev G; Krasheninnikova MA; Kolosovskaia VP; Chukanov VI
    Probl Tuberk; 1982 Jan; (1):58-62. PubMed ID: 7058194
    [No Abstract]   [Full Text] [Related]  

  • 32. [Results of routine treatment of pulmonary tuberculosis patients treated for the 1st time].
    Bernard E; Abadi O; Pretet S
    Rev Tuberc Pneumol (Paris); 1969 Nov; 33(7):967-74. PubMed ID: 5402999
    [No Abstract]   [Full Text] [Related]  

  • 33. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of immunosuppression on the action of antimycobacterial drugs in experimental tuberculosis. I. Effects of isoniazid, rifampicin and streptomycin on the survival of tuberculous mice immunosuppressed by azathioprine (Imuran).
    Trnka L; Kvapilová M; Mison P
    Chemotherapy; 1976; 22(6):353-61. PubMed ID: 954481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changes in the indication of surgical treatment for pulmonary tuberculosis in accordance with the introduction of rifampicin based on bacteriological findings on culture of resected specimens (author's transl)].
    Kekkaku; 1977 Jul; 52(7):353-60. PubMed ID: 409871
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical results of retreatment using rifampicin for more than 12 months for pulmonary tuberculosis (author's transl)].
    Urakami E; Nagasawa S
    Kekkaku; 1973 Sep; 48(9):411-6. PubMed ID: 4772413
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative study of the results of tuberculostatic agents with and without prednisolone in therapy of common phthisis].
    VERBEKE R; BEKAERT J; DE BRABANDERE R; GYSELEN A; STEYAERT J
    Acta Tuberc Belg; 1956 Dec; 47(6):439-57. PubMed ID: 13402557
    [No Abstract]   [Full Text] [Related]  

  • 38. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
    Ige OM; Bakare NA; Onadeko BO
    Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical study on rifampicin applied every other day for severe cavitary pulmonary tuberculosis (author's transl)].
    Kitatani F; Fujimoto S; Asahi T; Konishiike J; Sera Y
    Kekkaku; 1974 May; 49(5):133-8. PubMed ID: 4408937
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparative bacteriological development in 2 groups of patients with severe pulmonary tuberculosis, 1 treated with a rifampicin-base combination, the other with an INH-base combination].
    Augier J; Parrot R; Marchal G; Gillet P
    Rev Tuberc Pneumol (Paris); 1969; 33(3):414-23. PubMed ID: 5383011
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.